United States Últimas notícias

On this episode of Stock Movers with Alexis Christoforous: - Estee Lauder (EL) share are climbing following collapse of a proposed combination with Puig Brands that would have created one of the world's largest fragrance and skincare companies. - IMAX Corp. (IMAX) shares jumped after the Wall Street Journal reported the large-screen theater company is exploring a sale and has approached entertainment companies as potential buyers. - Ross Stores (ROST) shares are up after the off-price retailer boosted its comparable sales forecast for the full year. The firm also posted better-than-expected sales for the first quarter.

Federal Reserve Governor Christopher Waller now says he can't rule out voting to raise interest rates if inflation doesn't start to slow soon, saying "inflation is not headed in the right direction." Waller made the comments during a speech in Germany. Bloomberg's Michael McKee reports.

Stellantis is making a dramatic U-turn, bringing back affordable Chrysler SUVs, reviving Dodge muscle cars, and expanding Ram with new SUVs and pickups. As inflation crushes car buyers, the automaker is abandoning its luxury-first strategy to win back mainstream America. Bloomberg's Auto Reporter Gabrielle Coppola joined Bloomberg Open Interest to talk about the pivot and what's ahead for the carmaker.

The US State Department's point man for APEC says the group of 21 countries is an important customer for American goods and services - including energy. Bloomberg's Chief North Asia Correspondent Stephen Engle spoke with Casey Mace, the US senior official to APEC, on the sidelines of the APEC trade ministers meeting in China.

The U.S. Food and Drug Administration (FDA) has approved Datroway (datopotamab deruxtecan-dlnk) for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy.

Agios Pharmaceuticals (NASDAQ:AGIO) announced that the European Commission has granted marketing authorization for Pyrukynd (mitapivat) to treat anemia in adult patients with alpha- or beta-thalassemia.

Imperial Petroleum (NASDAQ:IMPP) announced its financial and operational results for the first quarter of 2026, marking the second-best quarterly performance in the ship-owning company’s history.

Functional Brands (NASDAQ:MEHA) announced it has signed a definitive agreement to acquire the Alchemy gold-backed blockchain settlement and decentralized finance (DeFi) platform from BullionFX.

Quanta Services (NYSE:PWR) announced today that its board of directors has authorized a new $1 billion stock repurchase program and declared its latest quarterly cash distribution.

NYSE President Lynn Martin says some of the rules used to attract SpaceX to go public on the Nasdaq are "questionable." She says "market integrity" is not a "competitive dynamic." Martin says it's been a good year for IPOs across all industries and they're working to bring more companies public. She speaks on "Bloomberg Surveillance."

Assembly Biosciences (NASDAQ:ASMB) announced plans to expand the clinical development framework for its experimental compound ABI-6250, pushing the asset beyond its initial virology target into chronic cholestatic liver conditions.

Enhertu (trastuzumab deruxtecan) moved a step closer to a milestone regulatory approval in Europe, securing a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) as a tumor-agnostic treatment for advanced solid malignancies.